Rhythm Pharmaceuticals Inc (RYTM) Insider Trading
- $22,046,700.00
- $61,331,696.60
- April 29, 2025
- Todd Foley
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
April 29, 2025 | Insider | 7,031 | $65.09 | Sell | $457,647.79 | |
April 29, 2025 | EVP | 6,745 | $65.08 | Sell | $438,964.60 | |
April 8, 2025 | Insider | 20,760 | $60.14 | Sell | $1,248,506.40 | |
April 8, 2025 | EVP | 17,750 | $60.99 | Sell | $1,082,572.50 | |
March 21, 2025 | CAO | 344 | $54.23 | Sell | $18,655.12 | |
March 14, 2025 | EVP | 75,000 | $51.48 | Sell | $3,861,000.00 | |
Feb. 19, 2025 | EVP | 2,035 | $57.22 | Sell | $116,442.70 | |
Feb. 19, 2025 | CFO | 2,215 | $57.22 | Sell | $126,742.30 | |
Feb. 19, 2025 | CAO | 635 | $57.22 | Sell | $36,334.70 | |
Feb. 19, 2025 | Insider | 1,228 | $57.22 | Sell | $70,266.16 | |
Feb. 19, 2025 | CEO | 9,896 | $57.22 | Sell | $566,249.12 | |
Feb. 12, 2025 | EVP | 1,815 | $56.39 | Sell | $102,347.85 | |
Feb. 11, 2025 | CFO | 1,296 | $57.51 | Sell | $74,532.96 | |
Feb. 11, 2025 | Insider | 794 | $57.51 | Sell | $45,662.94 | |
Feb. 10, 2025 | EVP | 4,189 | $58.91 | Sell | $246,773.99 | |
Feb. 4, 2025 | CEO | 4,278 | $59.43 | Sell | $254,241.54 | |
Feb. 4, 2025 | CFO | 1,678 | $59.43 | Sell | $99,723.54 | |
Feb. 4, 2025 | EVP | 1,447 | $59.43 | Sell | $85,995.21 | |
Feb. 4, 2025 | Insider | 1,281 | $59.43 | Sell | $76,129.83 | |
Nov. 11, 2024 | EVP | 66,861 | $66.33 | Sell | $4,434,890.13 | |
Nov. 11, 2024 | insider | 13,281 | $66.44 | Sell | $882,389.64 | |
Nov. 7, 2024 | Insider | 4,688 | $65.00 | Sell | $304,720.00 | |
Sept. 17, 2024 | Director | 31,751 | $52.40 | Sell | $1,663,752.40 | |
Sept. 10, 2024 | Director | 17,501 | $49.65 | Sell | $868,924.65 | |
Sept. 9, 2024 | Insider | 4,099 | $50.03 | Sell | $205,072.97 | |
Aug. 26, 2024 | Insider | 3,200 | $50.01 | Sell | $160,032.00 | |
Aug. 26, 2024 | Director | 4,300 | $50.01 | Sell | $215,043.00 | |
Aug. 9, 2024 | Insider | 49,006 | $45.15 | Sell | $2,212,620.90 | |
July 29, 2024 | Insider | 1,395 | $49.06 | Sell | $68,438.70 | |
July 16, 2024 | Insider | 10,468 | $53.00 | Sell | $554,804.00 | |
July 12, 2024 | Insider | 5,313 | $50.01 | Sell | $265,703.13 | |
May 9, 2024 | Insider | 3,984 | $38.47 | Sell | $153,264.48 | |
April 2, 2024 | CAO | 368 | $41.76 | Sell | $15,367.68 | |
March 21, 2024 | Insider | 18,235 | $40.34 | Sell | $735,599.90 | |
March 19, 2024 | EVP | 16,000 | $39.22 | Sell | $627,520.00 | |
March 19, 2024 | CFO | 15,515 | $39.22 | Sell | $608,498.30 | |
March 19, 2024 | CEO | 45,494 | $39.22 | Sell | $1,784,274.68 | |
Feb. 14, 2024 | Insider | 1,089 | $50.01 | Sell | $54,460.89 | |
Feb. 12, 2024 | EVP | 1,594 | $51.38 | Sell | $81,899.72 | |
Feb. 12, 2024 | Insider | 791 | $51.38 | Sell | $40,641.58 | |
Feb. 12, 2024 | CFO | 1,209 | $51.38 | Sell | $62,118.42 | |
Feb. 9, 2024 | Insider | 71,774 | $50.38 | Sell | $3,615,974.12 | |
Dec. 27, 2023 | Insider | 5,015 | $50.01 | Sell | $250,800.15 | |
Dec. 5, 2023 | CFO | 7,026 | $35.06 | Sell | $246,331.56 | |
Nov. 24, 2023 | CFO | 10,974 | $35.02 | Sell | $384,309.48 | |
Nov. 8, 2023 | EVP | 5,712 | $28.90 | Sell | $165,076.80 | |
Nov. 3, 2023 | EVP | 80 | $28.00 | Sell | $2,240.00 | |
Sept. 5, 2023 | EVP | 6,166 | $28.05 | Sell | $172,956.30 | |
Aug. 9, 2023 | EVP | 1,718 | $24.66 | Sell | $42,365.88 | |
Aug. 7, 2023 | EVP | 11,223 | $24.18 | Sell | $271,372.14 |
Insiders are both buying and selling Rhythm Pharmaceuticals Inc stock.
The insider traders at Rhythm Pharmaceuticals Inc are: Todd Foley, Joseph Shulman, Pamela J Cramer, Hunter C Smith, Jennifer Kayden Lee, Keith Michael Gottesdiener, Yann Mazabraud, Der Ploeg Leonardus H.T. Van, David P Meeker, Ra Capital Management, L.P., William T Roberts, Christopher Paul German, Jennifer Chien, Nithya Desikan, Lynn A Tetrault, Bros. Advisors Lp Baker, Jennifer L Good, James E Flynn, Orbimed Advisors Llc, and S.A. Ipsen
The most active insider trader at Rhythm Pharmaceuticals Inc is Todd Foley with 24 trades.
Todd Foley has sold the most Rhythm Pharmaceuticals Inc stock with a total value of $16,758,186.66.
Bros. Advisors Lp Baker has bought the most Rhythm Pharmaceuticals Inc stock with a total value of $30,090,000.00.
The most recent insider trade for Rhythm Pharmaceuticals Inc was on April 29, 2025.
The single biggest insider buy for Rhythm Pharmaceuticals Inc was from Bros. Advisors Lp Baker with a total value of $15,045,000.00 on Oct. 5, 2017.
The single biggest insider sell for Rhythm Pharmaceuticals Inc was from Jennifer Kayden Lee with a total value of $4,434,890.13 on Nov. 11, 2024.